Lantheus Holdings (LNTH) Other Non-Current Assets (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Other Non-Current Assets came in at $61.7 million in Q1 2026, up 69.31% year-on-year from $36.5 million in Q1 2025, and down 23.53% on a QoQ basis from $80.7 million in Q4 2025.

Lantheus Holdings (LNTH) Other Non-Current Assets (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Other Non-Current Assets data on file, last reported at $61.7 million in Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 69.31% year-over-year to $61.7 million in Q1 2026; TTM through Mar 2026 was $61.7 million, a 69.31% increase from a year earlier, with the FY2025 full-year figure at $80.7 million, up 82.52% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $61.7 million, down from $80.7 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for LNTH reached as high as $80.7 million in Q4 2025 and fell as low as $7.2 million in Q3 2023.
  • Historically, Other Non-Current Assets has averaged $32.7 million across 5 years, with a median of $36.5 million in 2025.
  • Across the five-year window, Other Non-Current Assets plunged 82.94% in 2023 and surged 650.4% in 2025, its largest moves.
  • Year by year, Other Non-Current Assets stood at $34.4 million in 2022, then tumbled by 79.16% to $7.2 million in 2023, then jumped by 517.92% to $44.2 million in 2024, then surged by 82.52% to $80.7 million in 2025, then slipped by 23.53% to $61.7 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $61.7 million in Q1 2026, $80.7 million in Q4 2025, and $53.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 89.51 Bn 87.64 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 36.00 Bn 32.26 Bn 1.97 Bn 1.79 Bn
3 Zoetis 32.61 Bn 30.67 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 27.49 Bn 23.43 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.05 Bn 20.90 Bn 648.10 Mn 233.20 Mn
6 RedHill Biopharma 21.48 Bn 21.48 Bn - 169,000.00
7 Viatris 20.26 Bn 18.46 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.79 Bn 16.47 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.64 Bn 12.21 Bn 785.00 Mn 295.00 Mn
10 Lantheus Holdings 6.97 Bn 6.47 Bn 230.92 Mn 61.74 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 61.74 Mn
Dec 31, 2025 80.74 Mn
Sep 30, 2025 53.72 Mn
Jun 30, 2025 36.39 Mn
Mar 31, 2025 36.47 Mn
Dec 31, 2024 44.24 Mn
Sep 30, 2024 7.16 Mn
Jun 30, 2024 7.16 Mn
Mar 31, 2024 7.16 Mn
Dec 31, 2023 7.16 Mn
Sep 30, 2023 7.16 Mn
Jun 30, 2023 39.13 Mn
Mar 31, 2023 7.20 Mn
Dec 31, 2022 34.36 Mn
Sep 30, 2022 41.63 Mn
Jun 30, 2022 42.16 Mn
Mar 31, 2022 42.20 Mn
Dec 31, 2021 38.76 Mn
Sep 30, 2021 45.29 Mn
Jun 30, 2021 61.87 Mn